Renaissance Technologies’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-599,151
Closed -$31.4M 3887
2020
Q3
$31.4M Buy
599,151
+182,900
+44% +$9.6M 0.03% 538
2020
Q2
$13.8M Buy
416,251
+359,237
+630% +$12M 0.01% 1031
2020
Q1
$1.55M Sell
57,014
-707,834
-93% -$19.3M ﹤0.01% 2193
2019
Q4
$15.1M Sell
764,848
-532,638
-41% -$10.5M 0.01% 1173
2019
Q3
$16.8M Sell
1,297,486
-319,804
-20% -$4.14M 0.01% 1061
2019
Q2
$20.1M Sell
1,617,290
-93,800
-5% -$1.17M 0.02% 961
2019
Q1
$24.9M Buy
1,711,090
+227,500
+15% +$3.31M 0.02% 861
2018
Q4
$16.4M Buy
1,483,590
+200,390
+16% +$2.21M 0.02% 1010
2018
Q3
$33.7M Sell
1,283,200
-95,300
-7% -$2.51M 0.03% 629
2018
Q2
$28.2M Sell
1,378,500
-44,900
-3% -$918K 0.03% 725
2018
Q1
$25.8M Sell
1,423,400
-159,600
-10% -$2.9M 0.03% 785
2017
Q4
$22.1M Buy
1,583,000
+134,500
+9% +$1.88M 0.02% 877
2017
Q3
$26.8M Buy
1,448,500
+651,100
+82% +$12M 0.03% 726
2017
Q2
$13.5M Buy
797,400
+519,000
+186% +$8.77M 0.02% 1081
2017
Q1
$3.72M Sell
278,400
-118,700
-30% -$1.58M 0.01% 1882
2016
Q4
$5.98M Buy
397,100
+104,300
+36% +$1.57M 0.01% 1546
2016
Q3
$3.42M Sell
292,800
-71,870
-20% -$840K 0.01% 1856
2016
Q2
$3.94M Sell
364,670
-664,381
-65% -$7.17M 0.01% 1767
2016
Q1
$9.51M Buy
1,029,051
+478,465
+87% +$4.42M 0.02% 1172
2015
Q4
$8.17M Buy
550,586
+112,220
+26% +$1.67M 0.02% 1132
2015
Q3
$7.19M Sell
438,366
-28,485
-6% -$467K 0.02% 1141
2015
Q2
$10.6M Buy
466,851
+232,400
+99% +$5.3M 0.02% 909
2015
Q1
$3.56M Buy
234,451
+4,100
+2% +$62.3K 0.01% 1575
2014
Q4
$2.77M Sell
230,351
-136,000
-37% -$1.64M 0.01% 1629
2014
Q3
$4.15M Sell
366,351
-173,900
-32% -$1.97M 0.01% 1259
2014
Q2
$6.53M Buy
540,251
+115,117
+27% +$1.39M 0.02% 1081
2014
Q1
$4.95M Buy
+425,134
New +$4.95M 0.01% 1253
2013
Q3
Sell
-59,751
Closed -$900K 3006
2013
Q2
$900K Buy
+59,751
New +$900K ﹤0.01% 1979